Disease Browser
|
Parent Node: Brain Neoplasms (D001932) | Parent Node: Prostatic Neoplasms (D011471) | ..Starting node ..PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (OMIM:603688)
| Child Nodes:
|
Sister Nodes: | ..Phyllodes Tumor of the Prostate (C549759)
| ..Prostate cancer, familial (C537243)
| ..PROSTATE CANCER, HEREDITARY, 1 (OMIM:601518)
| ..Prostate Cancer, Hereditary, 10 (C567011)
| ..Prostate Cancer, Hereditary, 11 (C567449)
| ..Prostate Cancer, Hereditary, 12 (C567510)
| ..Prostate Cancer, Hereditary, 13 (C567456)
| ..Prostate Cancer, Hereditary, 14 (C567448)
| ..Prostate Cancer, Hereditary, 15 (C567447)
| ..Prostate Cancer, Hereditary, 3 (C563883)
| ..Prostate Cancer, Hereditary, 4 (C563882)
| ..Prostate Cancer, Hereditary, 5 (C563744)
| ..Prostate Cancer, Hereditary, 6 (C563699)
| ..Prostate Cancer, Hereditary, 7 (C565201)
| ..Prostate Cancer, Hereditary, 8 (C566426)
| ..Prostate Cancer, Hereditary, 9 (C567031)
| ..PROSTATE CANCER, HEREDITARY, X-LINKED 1 (OMIM:300147)
| ..Prostate Cancer, Hereditary, X-Linked 2 (C567477)
| ..PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (OMIM:603688)
| ..Prostatic Neoplasms, Castration-Resistant (D064129)
|
Human Disease MESH is developed by UMLS. Further data from MedGen, OMIM, CTD
|
|
|
Term ID: | 9344 |
Name: | PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY |
Definition: | |
Alternative IDs: | |
ParentIDs: | MESH:D001932|MESH:D011471 |
TreeNumbers: | C04.588.614.250.195/603688 |C04.588.945.440.770/603688 |C10.228.140.211/603688 |C10.551.240.250/603688 |C12.294.260.750/603688 |C12.294.565.625/603688 |C12.758.409.750/603688 |
Synonyms: | CAPB |PCBC |
Slim Mappings: | Cancer|Nervous system disease|Urogenital disease (male) |
Reference: |
MedGen: 603688
MeSH: 603688
OMIM: 603688;
Genes: EPHB2; | Phenotypes | | Disease Causing ClinVar Variants | Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_004442.7(EPHB2):c.835G>T (p.Ala279Ser) | 2048 | EPHB2 | Pathogenic | 35882952 | RCV000009059; | N | MedGen:C1863600,OMIM:603688 | 1 | 23189553 | 23189553 | NM_004442.7:c.835G>T | NP_004433.2:p.Ala279Ser | NC_000001.10:g.23189553G>T | OMIM Allelic Variant:600997.0002 | C1863600 603688 Prostate cancer/brain cancer susceptibility | | | NM_004442.7(EPHB2):c.2035G>A (p.Asp679Asn) | 2048 | EPHB2 | Pathogenic | 28936395 | RCV000009060; | N | MedGen:C1863600,OMIM:603688 | 1 | 23233346 | 23233346 | NM_004442.7:c.2035G>A | NP_004433.2:p.Asp679Asn | NC_000001.10:g.23233346G>A | OMIM Allelic Variant:600997.0003 | C1863600 603688 Prostate cancer/brain cancer susceptibility | | | NM_004442.7(EPHB2):c.2167C>T (p.Gln723Ter) | 2048 | EPHB2 | Pathogenic | 121912582 | RCV000009058; | N | MedGen:C1863600,OMIM:603688 | 1 | 23234473 | 23234473 | NM_004442.7:c.2167C>T | NP_004433.2:p.Gln723Ter | NC_000001.10:g.23234473C>T | OMIM Allelic Variant:600997.0001 | C1863600 603688 Prostate cancer/brain cancer susceptibility | | | NM_001309193.1(EPHB2):c.3055A>T (p.Lys1019Ter) | 2048 | EPHB2 | risk factor | 76826147 | RCV000009061; | N | MedGen:C1863600,OMIM:603688 | 1 | 23240250 | 23240250 | NM_001309193.1:c.3055A>T | NP_001296122.1:p.Lys1019Ter | NC_000001.10:g.23240250A>T | OMIM Allelic Variant:600997.0004 | C1863600 603688 Prostate cancer/brain cancer susceptibility | | |
|
|